Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Herpes and warts treatment developer Henderson Morley says it is in ‘a late stage of negotiations’ about a collaboration deal.
The AIM-quoted company has responded to today’s doubling of its share price by dislosing it is discussing granting a licence for one of its portfolio of products to an unnamed life sciences company, which is also listed on AIM. Chairman Andrew Knight says these negotiations are at an advanced stage.
Henderson Morley, which lost a reduced £797,000 in the year to last April, claims its Ionic Contra Viral Therapy (ICVT) technology has potential applications for various forms of herpes, warts and verrucae. But the shares, which were floated at 4p on 2001, have not thrived, falling below 0.5p at one stage in 2005.
But buying today by canny punters – ahead of the company’s announcement – has lifted the shares from 1.5p to 3.05p, valuing the company at £8.7 million. Others must await the outcome of the talks.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.